Oatmeal Health

Main Features & Services: Oatmeal Health is a comprehensive AI-powered Virtual Lung Nodule Clinic designed for early detection. The platform uses AI to identify and screen high-risk patients for early cancer detection + diagnosis, starting with lung cancer for primary care, hospitals, and imaging centers. It integrates directly with PACS or existing CADe solutions; no additional software required.

Core Advantages & Features:

1. First CPT-Reimbursable AI Platform: For lung cancer screening + diagnosis.
2. Fewer False Positives: AI overreads low-dose Lung CT scans to identify malignancy risk faster.
3. Zero-Cost Solution: Offers a shared-revenue model that is fully reimbursable by Medicare, Medicaid, and most commercial payors.
4. Seamless Integration: Integrates directly with PACS or existing CADe solutions with no additional software required.
5. Improves Outcomes for Underserved Patients: Designed specifically for the most underserved patients of Community Health Centers and Health Systems.

Target Users:

1. Community Health Centers (FQHCs): Addresses under-resourced, understaffed, and overwhelmed challenges.
2. Imaging Centers: Provides CPT-reimbursable AI tools to improve diagnostic yield.
3. Health Systems / Hospitals.
4. Primary Care.
5. Pharma / Medtech / Biotech: Collaborates to tackle complex healthcare challenges nationwide.

Problems Addressed & Current State:

1. The U.S. is failing at cancer screening and early detection; lung cancer kills more than colon, breast, and prostate cancer combined, accounting for 27% of all cancer deaths.
2. Low Screening Rates: Fewer than 16% of eligible patients receive lung cancer screening, dropping below 6% at FQHCs.
3. Late-Stage Diagnoses Dominate: 85% of lung cancer cases are detected too late for effective intervention.
4. Limited Uptake of Billable AI: Imaging centers lack CPT-reimbursable AI tools to improve diagnostic yield.
5. Access Gaps Are Widening: FQHCs and rural health systems are under-resourced, understaffed, and overwhelmed.
6. Financially Devastating: Failing to detect lung cancer early results in over $150 billion in annual healthcare spending.

Pricing Model: Shared-revenue, zero-cost solution that is fully reimbursable by Medicare, Medicaid, and most commercial payors.